🔎 Trials Near Me

Beranda › Migrain › Tennessee

Uji klinis Migrain di Tennessee

8 studi untuk Migrain mencari peserta di lokasi di Tennessee.

Kota di Tennessee

Teks studi resmi (Bahasa Inggris)

Study of EVO756 in Adults With Migraine

  • Campbell Clinical Research, Franklin
Menerima pesertaFase 2
Usia 18 hingga 64 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07616128

MMA Embolization for Refractory Chronic Migraine

  • Semmes Murphey Foundation, Memphis
Menerima peserta
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06735833

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

  • Access Clinical Trials Inc /ID# 270280, Nashville
Menerima pesertaFase 3
Usia 12 hingga 17 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06810505

Responding With Evidence and Access for Childhood Headaches

  • University of Tennessee Health Science Center/ LeBonheur Children's Hospital, Memphis
Menerima peserta
Usia 10 hingga 17 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT05889624

Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

  • Vanderbilt Medical Center, Nashville
Menerima pesertaFase 4
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT06972056

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

  • Access Clinical Trials, Inc. /ID# 228002, Nashville
Menerima pesertaFase 3
Usia 6 hingga 17 · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT05125302

Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients

  • Clinical Research Associates, Inc., Nashville
Menerima pesertaFase 2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07646613

A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

  • WR-ClinSearch, LLC, Chattanooga
  • Access Clinical Trials, Inc, Nashville
  • Clinical Research Associates, Inc., Nashville
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT07645924

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.